The weight-loss drug Ozempic can help reduce stroke patients' risk of a heart attack or death, a new study says.
MedPage Today on MSN1d
ObesityWeek Roundup: Patients More Likely to Ration Weight-Loss DrugsSAN ANTONIO -- Research presented at the ObesityWeek annual meeting included studies on rationing of prescription medications ...
Semaglutide, the GLP-1 drug that Novo sells under the brand names Ozempic for diabetes and Wegovy for weight loss, has made ...
GLP-1s (glucagon-like peptide-1 receptor agonists) are medications used to treat type 2 diabetes and obesity. You’ve probably ...
HealthDay on MSN7d
Medicaid covers GLP-1 weight-loss drugs in just 13 statesOnly 13 states currently allow Medicaid to cover treatment of obesity using glucagon-like peptide-1 agonist (GLP-1) ...
"I'm using [Ozempic] off-label for a whole host of conditions — and have been for years," Dr. Caroline Messer, an ...
You can’t go far lately without seeing news and social media coverage of GLP-1 (glucagon-like peptide-1) receptor agonists ...
Use of glucagon-like peptide 1 receptor agonists (GLP-1 RAs) prior to bariatric surgery was safe but wasn’t associated with ...
Dallas Morning News on MSN5d
FDA adds new warning to weight loss drugs including WegovyThe FDA is warning that patients taking GLP-1s may be at a higher risk of inhaling fluid into their lungs while under ...
healthday on MSN12d
Most Patients Can Keep Using GLP-1 Weight Loss Meds Before SurgeriesA new guidance issued jointly by groups representing U.S. surgeons, anesthesiologists and gastroenterologists affirm ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback